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The small hydrophobic (SH) protein of mumps virus has been reported to interfere with innate 
immunity by inhibiting tumour necrosis factor alpha-mediated apoptosis. In a yeast two-hybrid screen 
we have identified the ataxin-1 ubiquitin-like interacting protein (A1Up) as a cellular target of the SH 
protein. A1Up contains an amino-terminal ubiquitin-like (UbL) domain, a carboxyterminal ubiquitin-
associated (UbA) domain and two stress-inducible heat shock chaperoninbinding (Sti1) motifs. This 
places it within the ubiquitin-like protein family that is involved in proteasome-mediated activities. Co-
immunoprecipitation confirmed the binding of SH and A1Up and demonstrates that a truncated protein 
fragment corresponding to aa 136–270 of A1Up, which represents the first Sti1-like repeat and an 
adjacent hydrophobic region, was sufficient for interaction, whereas neither the UbL nor the UbA 
domains were required for interaction. The ectopic expression of A1Up leads to a redistribution of SH 






Mumps virus (MuV) belongs to the family Paramyxoviridae, genus Rubulavirus. This enveloped virus 
contains a 15 384 nt non-segmented, ssRNA genome of negative polarity. MuV causes an acute 
communicable childhood disease characterized by fever and parotitis. The virus is transmitted via the 
respiratory route and is often disseminated to the CNS (Carbone & Rubin, 2007). Hence, MuV 
infection was the most common cause of aseptic meningitis prior to vaccination being available for it 
(Watson et al., 1998). 
 
The SH gene of MuV is highly variable. Consequently, a 316 nt fragment comprising the SH mRNA is 
used for MuV genotyping. Phylogenetic comparison of the SH gene from virus isolates has led to the 
definition of 12 MuV genotypes, which have been designated A–L (Jin et al., 2005). Recently a new 
genotype, M, was described (Santos et al., 2008). The SH (small hydrophobic) protein of MuV is 
expressed in MuV-infected cells but is not a constituent part of the virion (Takeuchi et al., 1996). SH is 
apparently non-essential for viral replication in cell culture, since the growth rate of cell culture-adapted 
strain Enders, which does not express the SH protein, is not restricted compared with wild-type MuV 
strains (Afzal et al., 1990; Takeuchi et al., 1991). Though the SH proteins of other paramyxoviruses, 
e.g. human respiratory syncytial virus (HRSV) and parainfluenza virus 5 (PIV5, formerly also named 
SV5), do not share any sequence homology with the MuV SH protein, all have been reported to be 
involved in blocking the tumour necrosis factor alpha (TNF-α)- mediated apoptosis pathway by 
inhibition of TNF- α signalling. Furthermore, a recombinant PIV5, in which the original SH has been 
  
replaced by that of HRSV or MuV, was able to block TNF- α -induced apoptosis (Fuentes et al., 2007; 
Wilson et al., 2006). In addition, the SH protein of HRSV has been predicted to act as a viroporin 
(Perez et al., 1997; Kochva et al., 2003). Viroporins are a group of highly hydrophobic small viral 
proteins that are able to homo-oligomerize and induce membrane permeability (Gonzalez & Carrasco, 
2003). 
 
The ataxin-1 ubiquitin-like interacting protein (A1Up), also known as ubiquilin 4, is involved in 
proteasome-mediated degradation of proteins and interacts with ataxin-1, a protein associated with the 
neurodegenerative disease spinocerebellar ataxia type 1 (Davidson et al., 2000). A1Up contains 
several protein motifs characteristic for ubiquilin proteins. These include an amino-terminal ubiquitin-
like (UbL) domain that is responsible for binding to the S5a subunit of the 19S proteasome (Hiyama et 
al., 1999) and a carboxy-terminal ubiquitin associated UbA domain that interacts with polyubiquitinated 
proteins and thereby initiates their proteasome-mediated degradation (Riley et al., 2004). A1Up also 
contains two stress-inducible heat shock chaperonin binding (Sti1) motifs that are known to bind to a 
wide range of cellular proteins. The first Sti1 motif of A1Up has been reported to bind to proteins with 
endoplasmic reticulum (ER) signal sequences. It is preceded by a hydrophobic region that enhances 
binding by attaching A1Up to the ER membrane via hydrophobic interactions (Matsuda et al., 2001). 
 
The role of the SH protein of MuV in the process of MuV infection is still largely unknown. For this 
study, we investigated the field of virus–host cell interaction to gain more detailed knowledge about 
the function of the SH protein. We determined early in this study that A1Up is a cellular interaction 





Cellular proteins binding to SH  
To identify cellular proteins interacting with the SH protein of MuV, the SH protein of the vaccine strain 
Jeryl Lynn 2 (SHJL) was used as bait in a yeast two-hybrid screen. Six million independent clones from 
a human cDNA library were screened for interaction with the SH protein. A total of 17 positive clones 
were rescued, sequenced and analysed by BLAST search. Similarity to three human proteins was 
found. Three clones matched the carboxy-terminal region of A1Up (601 aa; GenBank accession no. 
NP_064516), with the largest fragment (A1U0) showing 99% identity with the last 426 aa. One clone 
(GPR1250) showed 99% identity to the carboxyterminal 379 aa of human G protein-coupled receptor 
125 (GPR125, 1312 aa; GenBank accession no. NP_660333). Three clones corresponded to the 
human renin receptor (RR, 350 aa; GenBank accession no. NP_005756); clone RR0 was 100% 
identical to the carboxy-terminal 250 aa of the human RR. The remaining ten clones did not encode 
ORFs with marked similarity to known proteins. In the following we will focus on the interaction of SH 
and A1Up. The interaction of SH with the receptor proteins GPR125 and RR will be described 
elsewhere. A1U0 was retested for interaction by co-transformation with vector pGBKT7 or with the bait 
construct pBD–SHJL into yeast strain AH109 (Fig. 1a). Co-transformation was confirmed by growth on 
double drop-out (DDO) plates (Fig. 1a, lower panel), while growth of blue colonies on quadruple drop-
out plates containing X- α -Gal (QDO/X) plates implied interaction of the two proteins. When A1Uơ, 
RR0 and GPR1250 were tested for interaction with a wild-type MuV SH protein (SHwt), by yeast two 
hybrid screening, interaction was similarly observed (data not shown). 
 
 
Co-immunoprecipitation of SH and A1Up 
The physical interaction of both SHwt and SHJL with A1Up was confirmed by co-immunoprecipitation 
(co-IP). Haemagglutinin (HA)-tagged SH (pHA–SHwt) was coexpressed with Myc-tagged full-length 
A1Up (pMyc– A1Up) in 293 cells. The cells were lysed and incubated with rabbit anti-HA antiserum. 
The protein complexes were precipitated with protein G–Sepharose, separated by SDS-PAGE and 
analysed by immunoblotting. A1Up coprecipitated with the SH protein (Fig. 1b, lane 1). As negative 
controls, A1Up was either co-expressed with SH and then incubated with non-specific rabbit IgG (lane 
2) or solely expressed and then incubated with rabbit anti-HA (lane 3). Both negative controls showed 
no significant degree of co-precipitation; the faint band appearing in the latter case is presumably due 






Mapping the domains of A1Up for interaction with SH  
As a ubiquilin, A1Up contains an amino-terminal UbL domain, a carboxy-terminal UbA domain and two 
Sti1 motifs. A hydrophobic region precedes the first Sti1 motif. To investigate whether these elements 
are required for the interaction with SH, several truncated A1Up versions were constructed (Fig. 2a) 
and subjected to co-IP assays with the SH protein. A1Up fragments lacking the UbA domain 
(expressed by pMyc–ΔUbA), the UbL domain and the hydrophobic region (expressed by pMyc–A1U0) 
or both the UbA and UbL domains (expressed by pMyc– pMyc–A1UDUbL/A) co-precipitated with the SH 
protein (Fig. 2b, lanes 1a, 2a and 3a), implying that neither the UbL nor the UbA domain is necessary 
for binding SH. To investigate the role of the Sti1 motifs in the interaction with SH, truncated fragments 
of A1Up containing the Sti1 motifs in various combinations were tested. Fragment A1U136–270, 
comprising the first Sti1 motif and the hydrophobic region, interacted with SH (Fig. 2b, lane 5a), while 
A1U186–270, lacking the hydrophobic region and the amino-terminal fragment A1U1–143 did not (Fig. 2b, 
lanes 4a and 6a). A1U259–601, a larger fragment comprising the second Sti1 motif, exhibited a faint 
signal (Fig. 2b, lane 7a). None of the proteins tested was precipitated in the presence of non-specific 
rabbit IgG (Fig. 2b, lanes 1b–7b), which was used as the negative control. These results suggest that 
the interaction of A1Up and SH is not mediated by the UbL and UbA domains. Interaction occurred 
when either two Sti1 regions or the first Sti1 domain and the hydrophobic region were present. The 
hydrophobic region might be able to enhance the binding activity of the Sti1 region. A similar effect 
has been described for the interaction of UBIN, the murine A1Up homologue, and Hsp47 (Matsuda et 
al., 2001). The weak interaction observed for A1U259–601, which contains only the second Sti1 motif, in 
contrast to A1U186–270, which did not show any interacting capacity, might be due merely to the 
extension of the fragment to a size that allows correct folding of the protein. 
 
 
Subcellular localization of A1Up and SH 
To investigate whether SH and A1Up mutually affect their subcellular localization, 293 cells were 
transfected with pMyc–A1Up and pHA–SHwt and analysed by confocal laser scanning microscopy. We 
observed that A1Up formed a punctate pattern within the nucleus and the cytoplasm, as was reported 
by Davidson et al. (2000), and that the 20S proteasome co-localized with A1Up in these structures 
(Riley et al., 2004) (Fig. 3a). In cells transfected with SH alone, the proteasome showed an even 
distribution throughout the cell (Fig. 3b) as in non-transfected cells. Staining against protein disulfide 
isomerase (PDI) demonstrated that the SH protein was localized in the ER (Fig. 3b), as reported 
previously by Takeuchi et al. (1996). When pHA–SHwt and pMyc–A1Up were co-expressed, SH was 
partially redistributed to co-localize with A1Up and the 20S proteasome in the aforementioned 
punctuate structures (Fig. 3c), which did not co-localize with the ER marker PDI (Fig. 3d). These 
results demonstrate that A1Up transports the SH protein of MuV to the proteasome. When these 
experiments were performed with SHJL, the results did not deviate from this (data not shown). To rule 
out that this effect is related to the ectopic expression of SH, we have investigated the subcellular 
localization of SH and A1Up in MuV-infected cells (Fig. 4). Vero cells were infected with rMuV EGFP–
SH and subsequently transfected with pMyc–A1Up. The EGFP–SH fusion protein expressed by the 
recombinant virus co-localized with PDI (Fig. 4a) and showed a distribution similar to the ectopically 
expressed SH in 293 cells. Co-expression with A1Up resulted in redistribution of EGFP–SH to the 
punctiform structures harbouring A1Up and the proteasome (Fig. 4b). This demonstrates that the 
interaction of SH and A1Up and the transport of SH to the proteasome are also observed in the 
context of an MuV infection. 
 
 
Stability of SH and A1Up 
The proteasome is a cellular compartment involved in protein degradation. To study whether the 
formation of the complex of SH and A1Up and its subsequent transport to the proteasome results in 
the degradation of SH, pHA–SHwt and pMyc–A1Up were co-transfected into 293 cells. The plasmids 
were co-transfected with pCMV–HA and pCMV–Myc, respectively, to serve as negative controls. After 
48 h, cycloheximide was added to shut down protein synthesis. The amount of SH in the presence or 
absence of A1Up was compared at different times following cycloheximide treatment. In a reciprocal 
experiment, the stability of A1Up in the presence of SH was determined. Neither the degradation rate 
of the SH protein, nor the stability of A1Up, was affected significantly by the presence of their 
interaction partner (Fig. 5). This experiment was also performed with SHJL and gave similar results 







In this study we have identified A1Up as a cellular target of the SH protein of MuV. The interaction was 
demonstrated using yeast two-hybrid and co-IP studies. Moreover, the partial redistribution of SH from 
the ER to the proteasome after co-expression with A1Up provided additional evidence that both 
proteins interact specifically. Observations of binding and subcellular redistribution of SH were equal 
for the SH protein of the live attenuated vaccine Jeryl Lynn and for that of a wild-type MuV of genotype 
G, indicating that the attenuation of the MuV vaccine strain did not affect the capacity of SH to interact 
with A1Up. 
 
Since the original parent wild-type viruses are lost, and are thus not available for sequencing, they 
cannot be compared with current vaccines. Therefore, knowledge about the genetic changes 
responsible for the loss of virulence is rather scant. Sequence deviations have been described with 
respect to virulence (Yates et al., 1996) and neurovirulence (Rubin et al., 2003; Lemon et al., 2007), 
but a genetic marker for attenuation has not yet been defined. Here, we have compared the SH 
protein of a wild-type MuV and a vaccine. The SH gene is the most variable part of the MuV genome; 
the sequences of SHwt and SHJL differ by 11 aa (19 %). In this study, no differences with respect to 
interaction and cellular localization were observed, suggesting that attenuation of MuV does not 
interfere with the interaction with A1Up. A1Up is one of four highly conserved human ubiquilin 
proteins. Ubiquilins contain a UbL domain that mediates their interaction with the 19S subunit of the 
proteasome, a UbA domain that feeds proteins into the ubiquitin–proteasome pathway and two Sti1 
motifs. When co-expressed with A1Up, SH was redistributed to the cytoplasm to co-localize with A1Up 
and the proteasome. This observation suggested that A1Up might bind SH via the UbA domain and 
thus eventually effectuate an increased degradation rate of the SH protein. We eliminated this 
suggestion by demonstrating that the capacity of A1Up to bind SH is independent of the presence of 
the UbA domain, and that furthermore the interaction partners do not mutually influence their 
degradation rate. This suggests other implications for the SH–A1Up interaction. 
 
Using truncated versions of A1Up we were able to narrow down the location of the interacting domain 
to the first Sti1 motif and the preceding hydrophobic region. In the case of UBIN, a murine homologue 
of A1Up, the corresponding region is responsible for the interaction with the ER-targeting signal 
sequence of Hsp47 (Matsuda et al., 2001). Hsp47, an ER-resident stress-inducible glycoprotein, 
functions as a collagen-specific molecular chaperone (Nagata, 1996). For human ubiquilin 1 and 2, it 
was shown that the carboxy-terminal Sti1 motif binds to the ATPase domain of the Hsp70-like Stch 
protein (Kaye et al., 2000). Bag-1, another Sti1-like-repeat-containing protein, interacts with Hsp70 
and thereby inhibits the chaperone activity of Hsp70 (Takayama et al., 1997). Hsp70 modulates NF-kB 
signalling pathways in the apoptotic cascade and also acts as an inhibitor of apoptosis at multiple 
levels, e.g. inhibition of the activation of initiator caspases and inhibition of Bax translocation to the 
mitochondria (Arya et al., 2007). The MuV SH protein might fit into this picture as a regulator of a 
potential interaction between A1Up and Hsp70. Moreover, the binding of SH to A1Up could stabilize 
A1Up in its putatively active monomeric form by occupying the central region of the protein. This part 
of the protein mediates the formation of protein dimers, which was previously shown for ubiquilin 1 and 
2 (Ford & Monteiro, 2006). K7, another small hydrophobic protein encoded by Kaposi’s 
sarcomaassociated herpesvirus (HHV8) that protects cells from apoptosis, interacts with ubiquilin 1. 
K7 inhibits ubiquilin 1 from binding to and thereby stabilizing IkB, a regulator of the NF-kB signalling 
pathway, which eventually results in the rapid degradation of IkB and p53 (Feng et al., 2004). We 
found that the MuV SH protein interacts with ubiquilin 1 as well (data not shown). This might suggest 
that, for both A1Up and ubiquilin 1, binding to SH interferes with their usual cellular function. Moreover, 
this may contribute to the dysregulation of the TNF-α-mediated apoptosis pathway, resulting in an anti-
apoptotic function. Many viral proteins use several of a wide range of cellular targets to subvert the 
apoptotic process. The K7 protein of HHV8, for instance, interferes with a number of apoptotic 
pathways: apart from modulating NF-kB signalling as mentioned above, it also activates the calcium-
modulating cyclophilin ligand, which results in an increase in the cytosolic Ca2+ concentration (Feng et 
al., 2002). Furthermore, K7 binds to Bcl-2 and caspase 3, thus inhibiting caspase activity (Wang et al., 
2002). A main feature of paramyxovirus SH proteins is their capacity to inhibit the TNF-a-mediated 
apoptosis pathway. Beyond that property, the SH protein of HRSV has been reported to act as an ion 
channel-forming viroporin as well (Kochva et al., 2003; Perez et al., 1997). Some viroporins have the 
capacity to suppress the induction of apoptosis by manipulating intracellular Ca2+ homeostasis, as has 
been described for the 2B protein of coxsackievirus (Campanella et al., 2004). The molecular 
mechanisms underlying the MuV SH protein’s interference with cellular pathways to prevent the 
induction of apoptosis, and the role that A1Up plays in this context, remain to be investigated in more 
  
detail. Also to be investigated are the involvement of GPR125 and RR, which were not explored in this 
study.  
 
In summary, our results revealed new functional aspects of the SH protein, linking it to the 
proteasome-mediated degradation machinery and to chaperone activities, which might be modulated 





Cell culture, viruses and plasmids. 293 and Vero cells were grown in Dulbecco’s modified Eagle’s 
medium supplemented with 5% (v/v) FCS at 37 uC and 5% CO2. MuV vaccine strain Jeryl Lynn (Afzal 
et al., 1993) and wild-type strain 05-063 (isolated in 2005 at the National Reference Centre Measles, 
Mumps, Rubella) were cultivated in Vero cells. Viral RNA was extracted using a QIAamp Viral RNA 
Mini Kit (Qiagen) and synthesis of cDNA was performed with MMLV-reverse transcriptase (RT) 
(Invitrogen) and primer Mu21F (Supplementary Table S1; available in JGV Online). DNA fragments 
were amplified with restriction site-tagged primers (Supplementary Table S1) and PCR products were 
inserted via restriction sites which were introduced into the plasmids using standard techniques 
(Sambrook & Russell, 2001). The MuV vaccine Jeryl Lynn is composed of two substrains, JL2 and 
JL5, present in a 1 : 5 ratio (Afzal et al., 1993). The SH gene of JL2 (SHJL) was amplified with primers 
MuSH22F and MuSH23R and cloned into pGBKT7 (Clontech) to obtain construct pBD–SHJL. For 
construction of pHA–SHJL, SHJL was amplified with primers MuSH22F and MuSH36R and inserted into 
pCMV–HA (Clontech). SHwt was amplified with primers MuSH71F and MuSH72R and cloned into 
pGBKT7 and pCMV–HA to obtain plasmids pBD–SHwt and pHA– SHwt. The cDNA library plasmid 
pACT–A1U0 was subcloned into pCMV–Myc (Clontech) to produce pMyc–A1U0. A full-length cDNA 
clone of A1Up (BC081403) was purchased (RZPD; Imagenes) and used as a template for the  
amplification of PCR products cloned into pCMV–Myc. The resultant plasmids and the primer pairs 
employed were: pMyc–A1Up, Mu206F and Mu68R; pMyc–A1UΔUbA, Mu206F and 3050; pMyc–
A1UΔUbL, 3049 and Mu68R; pMyc–A1UΔUbL/A, 3049 and 3050; pMyc–136-270, 3088 and 3091; pMyc–




Generation of recombinant MuV from cDNA.  
The SH gene of the vaccine strain JL5 was amplified from the plasmid pMuV(MPBS) (Lemon et al., 
2007) using primers EGFP–SH+ and Mu7307R (Supplementary Table S1). The EGFP gene was 
amplified from plasmid pEGFP-N1 (Clontech) using primers EGFP–SHF and EGFP–SH 
(Supplementary Table S1). Overlap extension PCR was used to join the two PCR fragments. The 
resulting product contained the EGFP ORF fused to the SH ORF via a 5 aa linker (GAGQG). This was 
cloned into pMuV(MPBS) using the unique BtrI and SgfI restriction sites to generate pMuV–EGFP–SH. 
A549 cells were infected with MVA–T7 at an m.o.i. of 0.5 and transfected with pMuV–EGFP–SH along 
with plasmids encoding MuV N, P and L as described previously (Lemon et al., 2007). Extensive CPE 
was observed following the addition of Vero cells to the transfected monolayers. Plaque-purified virus 
was passaged three times on Vero cells.  
 
 
Yeast two-hybrid library screen.  
The Matchmaker Gal4 Two-Hybrid System 3 (Clontech) was applied according to the manufacturer’s 
instructions. Yeast strain AH109 (Clontech) was transformed simultaneously with bait (pBD–SHJL) and 
prey (cDNA library derived from human liver; Clontech) plasmids. Transformed cells were selected on 
QDO plates lacking adenine, histidine, tryptophan and leucine. Yeast colonies were replated on 
QDO/X plates containing X-a-Gal (Biosynth) to test for α-galactosidase expression. Blue colonies were 
subcultured on QDO/X plates to rescue additional library plasmids and to eliminate false positives. For 
plasmid isolation from yeast cells, colonies were grown in DDO medium (lacking leucine and 
tryptophan) at 30 °C and 200 r.p.m. for 48 h. (Innova 4430; New Brunswick Scientific) After 
precipitation, cells were resuspended in 10 ųl lyticase (5 U ml-1; Sigma-Aldrich) and incubated for 1 h 
at 37 °C and 250 r.p.m. (Innova 4430; New Brunswick Scientific) Ten microlitres of 20% SDS was 
added and plasmids were extracted after a freeze–thaw cycle using a DNA Mini Kit (Qiagen). 
Escherichia coli DH5α cells were transformed with the DNA samples and prey plasmids were 
extracted and sequenced. A BLAST analysis was performed using the NCBI BLASTP program.  
 
  
Immunoprecipitation and immunoblot analysis.  
293 cells were grown in six-well plates and transfected simultaneously with 200 ng plasmid DNA of 
pCMV–Myc-based constructs expressing full-length or truncated versions of A1Up and 200 ng of 
pHA–SHwt or pCMV–HA, using Effectene transfection reagent (Qiagen). Forty-eight hours post-
transfection, cells were washed with PBS (pH 7.2) and incubated on ice for 1 h in 1 ml lysis buffer [150 
mMNaCl, 5 mMMgCl2, 20 mM Tris/HCl pH 8, 1 mM EDTA, 1% IGEPAL (Rhodia)] containing one tablet 
complete mini protease inhibitor per 20 ml (Roche Diagnostics). After the addition of rabbit anti-HA 
antibody (Hiss Diagnostics) or non-specific rabbit IgG (Dianova), samples were incubated for 2 h at 4 
°C. Then 20 µl of protein G–Sepharose was added, followed by incubation for 2 h at 4 °C. The 
adsorbates were washed four times in PBS (pH 7.2) with 0.2% IGEPAL and subjected to SDS-PAGE 
(11% acrylamide). Aliquots of complete cell lysates (50 µl) were included as input controls. Proteins 
were electrophoretically transferred to a PVDF membrane (Millipore). The membranes were blocked 
with 5% milk powder in PBS (pH 7.2) and 0.05% Tween 20 (PBS-T), and probed with monoclonal anti-
HA, anti-Myc or anti-β-actin antibodies (Sigma). The membranes were washed and incubated with 
HRPconjugated goat anti-mouse antiserum (Dianova). The antigen– antibody complexes were 
visualized by chemiluminescence using an ECL-Western blotting detection system (Amersham).  
 
 
Immunofluorescence analysis.  
293 cells were grown on coverslips in 24-well plates. For each transfection, a total of 200 ng plasmid 
DNA was used. Cells were either simultaneously transfected with pHA–SHwt and pMyc–A1Up or were 
singly transfected. Twenty-four hours after transfection, cells were fixed with 4% paraformaldehyde in 
PBS (pH 7.2) and permeabilized with 0.1% Triton X-100 in PBS (pH 7.2). The primary antibodies were 
labelled with the respective Fab conjugates in separate reactions. The antibody and the respective 
Fab fragment were mixed, incubated for 20 min at room temperature and then non-bound Fab 
conjugates were captured by adding a large excess of non-specific mouse, rabbit or goat IgG 
(Dianova) and incubating for 15 min at room temperature. The labelled antibodies were then diluted in 
blocking solution and added to the cells for 1 h. HA- or Myc-tagged proteins were detected with 
monoclonal anti-HA or anti-Myc antibodies (Sigma). ER staining was performed with monoclonal anti-
PDI antibody (Acris Antibodies) and the proteasome was detected with rabbit anti-20S proteasome 
antiserum (Biomol). Cells were washed and nuclei were stained with DAPI (Roth) in PBS-T with 2% 
BSA for 5 min. Coverslips were mounted in Mowiol (Merck Biosciences) and analysed by confocal 
laser scanning microscopy (LSM 510; Zeiss). Visualization of DAPI was performed at 355 nm, Cy2-
labelled proteins were detected at 488 nm, Cy3-labelled proteins at 594 nm and Cy5-labelled proteins 
at 688 nm.  
 
 
Degradation rates of SH and A1Up.  
293 cells were grown in sixwell plates and co-transfected with 200 ng pHA–SHwt and pCMV– Myc or 
pHA–SHwt and pMyc–A1Up, using the Effectene transfection reagent (Qiagen). Twenty-four hours 
after transfection, cells were split 1 : 10 into 96-well plates and incubated with 50 ng cycloheximide ml-
1 (Sigma) for the indicated time (see Fig. 5), followed by fixation with a 1 : 1 solution of 
methanol/acetone for 15 min at 220 °C. Cells were blocked for 1 h in PBS-T containing 2% milk 
powder and incubated for 1 h with monoclonal anti-Myc or anti-HA antibody (Sigma). After five 
washing steps, cells were incubated for 45 min with HRP-conjugated goat anti-mouse antiserum 
(Dianova) in blocking buffer. Fifty microlitres of 3,39’,5,5’-tetramethylbenzidine substrate per well was 
added and after 20 min the reaction was stopped with an equal amount of 1M H2SO4. Reaction 
intensity was measured at 450 nm with 620 nm as the reference using an ELISA reader (FLUOstar 
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Figure 1. (a) Interaction of MuV SHJL and A1U0 shown in a yeast two-hybrid assay. Yeast strain 
AH109 was co-transformed with pBD–SHJL and pACT–A1U0. Interaction of SHJL with the A1U0 
fragment is indicated by growth of colonies on the QDO/X plate (upper panel, middle section). SHJL 
and A1U0 showed negative results for autoactivation (upper panel, right and left section). Colonies on 
DDO plates indicate co-transformation of bait and prey plasmids, respectively (lower panel). (b) Co-
immunoprecipitation (co-IP) of A1Up with the SH protein. 293 cells were cotransfected with plasmids 
pMyc–A1Up and pHA–SHwt (lanes 1 and 2) or pMyc–A1Up and pCMV–HA (lane 3). Cell lysates were 
subjected to co-IP with rabbit anti-HA antiserum or non-specific rabbit IgG antiserum, as indicated, and 
protein G–Sepharose. Proteins were separated by SDS-PAGE, then blotted and detected with mouse 
anti-Myc and anti-HA antibodies. As expression controls for the proteins, the respective cell lysates 
were immunoblotted using mouse anti-Myc and anti-HA antibodies (lanes 1c, 2c and 3c). Detection of 











Figure 2. Mapping of the interacting domain of A1Up. (a) Map of A1Up. Protein motifs indicated are: 
UbL, ubiquitin-like domain; UbA, ubiquitin-associated domain; Sti1, stress-inducible heat shock 
chaperonin-binding motifs; and H, hydrophobic region. Binding activity of the A1Up fragments to SH is 
summarized to the right. (b) Co-IP of A1Up fragments. 293 cells were co-transfected with pHA–SHwt in 
combination with pMyc-ΔUbA(1a–1c), pMyc– A1UΔUbA (2a–2c), pMyc–(3a–3c), pMyc–A1U1–143 (4a– 4c), 
pMyc–A1U136–270 (5a–5c), pMyc– A1U186–270 (6a–6c) or pMyc–A1U259–601 (7a–7c). Cell lysates were 
immunoprecipitated with rabbit anti-HA (1a–7a) or non-specific rabbit IgG antiserum (1b–7b) and 
protein G–Sepharose. Precipitated proteins were analysed by immunoblotting with mouse anti-Myc 
and anti-HA antibodies (upper panel). Arrowheads indicate the position of precipitated interacting 
proteins (top right). Ig-LC indicates the immunoglobulin light chain. Protein expression in cell lysates 
was examined by immunoblotting using Myc- and HAspecific mouse antibodies (1c–7c). Detection of 








Figure 3. Intracellular distribution of SH and A1Up. Subcellular localization of HA–SHwt and Myc–
A1Up was analysed in 293 cells 24 h post-transfection with pHA–SHwt and pMyc–A1Up. Transfected 
cells were fixed and subjected to immunofluorescence analysis using mouse monoclonal anti-HA, anti-
Myc and anti-PDI antibodies as an ER marker and rabbit anti-20S proteasome antiserum, in 
conjunction with the respective goat anti-mouse or anti-rabbit Fab fragments conjugated with Cy2 
(green), Cy3 (red) or Cy5 (white). The smaller sized pictures show a close-up of the rectangular range 
within the larger image. (a) Solely expressed Myc–A1Up (green) co-stained with 20S proteasome 
(white) and PDI (red). (b) Solely expressed HA–SH (green) costained with 20S proteasome (white) 
and PDI (red). (c) Co-expressed Myc–A1Up (red) and HA–SH (green) co-stained with 20S 





























Figure 4. Subcellular localization of SH and A1Up in MuV-infected cells. (a) Vero cells were infected 
with rMuV EGFP–SH at an m.o.i. of 0.1. Forty-eight hours after infection cells were fixed and stained 
with anti-PDI antibody in conjunction with an Alexa Fluor 568-conjugated anti-rabbit secondary 
antibody (Molecular Probes). Pictures were taken by confocal laser scanning microscopy (Leica SP5). 
(b) Vero cells were infected with rMuV EGFP–SH at an m.o.i. of 0.1 and transfected with pMyc–A1Up. 
After 48 h, cells were fixed and stained with anti-Myc antibody in conjunction with Alexa Fluor 568-
conjugated anti-mouse secondary antibody (Molecular Probes). The lower row shows close-ups of the 






























Figure 5. Stability of A1Up and SH. 293 cells were co-transfected  with pMyc–A1Up and pHA–SHwt, 
while pMyc–A1Up/pCMV–HA and pHA–SH/pCMV–Myc were used as negative controls. Fortyeight 
hours after transfection, cells were incubated with 50 ng cycloheximide ml”1. At 0, 2 and 6 h post 
treatment, cells were fixed and A1Up and SH protein levels were determined in quadruplicate by 
indirect ELISA using mouse monoclonal anti- HA and anti-Myc, and peroxidase-conjugated goat anti-
mouse antibodies. Circles indicate the degradation of A1Up in the presence (●) and absence (○) of 
SH. ▲ and Δ indicate the reciprocal experiment for A1Up. 
 
 
 
  
